Skip to main content
JAMA Network logoLink to JAMA Network
. 2024 May 1;9(7):674. doi: 10.1001/jamacardio.2024.1006

Error in Figure 3

PMCID: PMC11063919  PMID: 38691370

The Original Investigation titled “Effect of Mavacamten on Chinese Patients With Symptomatic Obstructive Hypertrophic Cardiomyopathy: The EXPLORER-CN Randomized Clinical Trial,”1 published online August 28, 2023, and in the October issue of JAMA Cardiology was corrected to fix an error in Figure 3. The upper confidence limit of the 95% CI at the bottom of the “LSM difference” column in the forest plot was changed from “−14.0” to “14.0.” This article was corrected online.

Reference

  • 1.Tian Z, Li L, Li X, et al. Effect of mavacamten on Chinese patients with symptomatic obstructive hypertrophic cardiomyopathy: the EXPLORER-CN randomized clinical trial. JAMA Cardiol. 2023;8(10):957-965. doi: 10.1001/jamacardio.2023.3030 [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from JAMA Cardiology are provided here courtesy of American Medical Association

RESOURCES